PNNL’s longstanding grid and buildings capabilities are driving two projects that test transactive energy concepts on a grand scale and lay the groundwork for a more efficient U.S. energy system.
Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.
An award-winning ion separation technology developed at PNNL has been licensed for biomedical applications. Continued research aims to make the devices suitable for molecular analysis in the field.
Soil microbial communities produced more water retaining molecules when enriched with insoluble organic carbon, chitin, compared to a soluble carbon source, N-acetylglucosamine.
The Facility Cybersecurity toolkit, developed by PNNL, is designed for federal facilities to help implement the presidential executive order on cybersecurity, but it is also available for commercial facilities without charge.
Using a large repository of blood samples from military personnel, PNNL and Uniformed Services University scientists have discovered a group of 13 proteins that could provide early detection of head and neck cancers.
PNNL building energy-efficiency expert Theresa Gilbride has been invited to participate in a new task group that will provide guidance to make homes more resistant to hurricanes and high winds.
The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.